Home

Needle-free drug delivery device scoops top award

The Glide Solid Dose Injector (SDI), the needle-free drug delivery system that injects drugs in solid dosage form into the skin, has contributed to its manufacturer, Glide Pharma, winning the Best Business Award at the 2007 Medical Futures Innovation Awards.

The competition had attracted over 500 entries. The Best Business Award is given to the overall winner from among the 25 award winners. Glide Pharma located at Milton Park, Oxfordshire, also won the Best Business Proposition Award in the Anaesthesia & Critical Care category, sponsored by Abbott Laboratories.

Ease of use also makes it ideal for self-administration e.g. by diabetics, and the device also eliminates needlestick injury and disposal problems.

Glide Pharma is developing a range of new drug products for use with the system, the first of these to commence clinical trials shortly. This contains the drug octreotide acetate, a top seller from Novartis that recently came ‘off patent’. It is used to treat neuro-endocrine tumours prior to surgery, as well as acromegaly, a chronic condition caused by abnormally high amounts of growth hormone.

Dr Charles Potter, Founder & CEO of Glide Pharma, receives the Best Business Award 2007 from actress Joanna Lumley at the Medical Futures Innovation Awards Ceremony.
Left to right: Joanna Lumley OBE; Chris Gorman OBE; Dr Charles Potter (Founder & CEO, Glide Pharma) and Roberto Solari (CEO, MRC Technology)

Dr Charles Potter, Founder and CEO of Glide Pharma, received the Best Business Award at a glittering ceremony in London. He said the award had come at a time when the company is making excellent progress in production and partnerships, and is advancing the first of its own brand products, and negotiating with many major pharmaceutical partners to co-develop the Glide Solid Dose Injector with their proprietary drugs and vaccines.

The Medical Futures Awards judging panel included leading healthcare experts such as Sir Magdi Yacoub, pioneer of the heart and lung transplant; Baroness Susan Greenfield, Professor of Pharmacology at the University of Oxford; and Sir Richard Sykes, former Chairman and CEO of GlaxoSmithKline and currently Rector of Imperial College. Complemented by business experts, such as Sir Victor Blank, Chairman of Lloyds TSB Group Plc; and Sir Michael Sherwood, Chief Executive of Goldman Sachs, the panel is Europe’s leading think tank on health and business innovation.

Andy Goldberg, founder of Medical Futures, said: ‘Nine out of 10 of the largest medical technology companies are US-based, yet the UK produces some of the world’s best ideas. Medical Futures has demonstrated a strong pipeline of innovations set to become the next high growth area and prove that the UK can be a world beater.’

This article was published on 08/31/2007

Search

Service

Subscribe to Newsletter

Subscribe to Journal

Tell a friend

EH Competition

Company News

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.